BRIEF-Lilly, Adocia announce Positive topline results from a Phase 1b study of Lispro U100
April 27, 2016 at 12:04 PM EDT
* Adocia and lilly announce positive topline results from a phase 1b study of repeated administration of ultra-rapid Biochaperone Lispro U100 in people with type 2 Diabetes
